Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular basis of thrombolytic therapy.

× No keyword cloud information.

41 in total

1. On the kinetics of the reaction between human antiplasmin and plasmin.

Authors: B Wiman; D Collen
Journal: Eur J Biochem Date: 1978-03-15

Review 2. The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis.

Authors: S Thorsen
Journal: Ann N Y Acad Sci Date: 1992-12-04 Impact factor: 5.691

Review 3. Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent.

Authors: D Collen
Journal: Nat Med Date: 1998-03 Impact factor: 53.440

Review 4. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.

Authors: M Nesheim; W Wang; M Boffa; M Nagashima; J Morser; L Bajzar
Journal: Thromb Haemost Date: 1997-07 Impact factor: 5.249

5. Role of alpha 2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasma.

Authors: P J Declerck; H R Lijnen; M Verstreken; D Collen
Journal: Thromb Haemost Date: 1991-04-08 Impact factor: 5.249

Review 6. Plasminogen activator inhibitors--a review.

Authors: E K Kruithof
Journal: Enzyme Date: 1988

7. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial.

Authors: C P Cannon; C H McCabe; C M Gibson; M Ghali; R F Sequeira; G R McKendall; J Breed; N B Modi; N L Fox; R P Tracy; T W Love; E Braunwald
Journal: Circulation Date: 1997-01-21 Impact factor: 29.690

8. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).

Authors: P J Declerck; M De Mol; M C Alessi; S Baudner; E P Pâques; K T Preissner; G Müller-Berghaus; D Collen
Journal: J Biol Chem Date: 1988-10-25 Impact factor: 5.157

Molecular basis of thrombolytic therapy.